Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q4 2025 Earnings Call Transcript February 12, 2026
Agios Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-1.86, expectations were $-1.97.
Operator: Good morning and welcome to Agios Pharmaceuticals, Inc. Fourth Quarter and Full Year 2025 Conference Call. At this time, participants are in a listen-only mode. There will be a question and answer session at the end. Please be advised that this call is being recorded at Agios...
